AIPM in the Republic of Kazakhstan would like to invite all participants of the medical drugs distri
AIPM in the Republic of Kazakhstan would like to invite all participants of the medical drugs distribution chain to sign the Code of Ethics for the Promotion of Medicines. This is an important step towards establishing a transparent competitive environment on the Kazakh pharmaceutical market.READ FULL VERSION OF THE CODE OF ETHICS FOR THE PROMOTION OF MEDICINES
News and Events
Kazakhstan and Sweden Exchanged Experiences in Healthcare System Management
02 May 2023 - 70 Views"The future of healthcare: exchange of Swedish and Kazakh experiences in managing the healthcare system" round table was held in Astana with participation of Kazakhstan Ministry of Health and Swedish National Board of Health and
...
Russia Will Register Drug only in Accordance with EAEU Rules since 2021
09 January 2020 - 1141 ViewsThe Ministry of Industry and Trade of the Russian Federation proposes from January 1, 2021 to register new drugs for medical use only within the framework of the rules of the Eurasian Economic Union, the press service of the
Gilead Filgotinib Proved Successful in Trial Evaluating Efficacy and Safety
12 December 2019 - 1052 ViewsGilead has announced that its investigational rheumatoid arthritis (RA) drug, filgotinib, has proved successful in a trial evaluating its efficacy and safety when treating moderately-to-severely active versions of the
FDA Approved New Diagnostic Test Based on Bacterial Viability
12 December 2019 - 1079 ViewsThe U.S. Food and Drug Administration authorized marketing of a new diagnostic test based on bacterial viability and novel technology to detect Methicillin-resistant Staphylococcus aureus (MRSA) bacterial
Novartis to Submit 80 Major Marketing Applications for its Drugs from 2020 to 2022
12 December 2019 - 1067 ViewsNovartis said Thursday ahead of a meeting with analysts and investors that it expects to submit more than 80 major marketing applications for its drugs from 2020 to 2022 in the US, Europe, Japan and China. CEO Vas Narasimhan
AbbVie Announced Collaboration with Scripps Research to Develop New Therapies
12 December 2019 - 1054 ViewsAbbVie, a research-based global biopharmaceutical company and Scripps Research, an international leader in non-profit biomedical research and drug discovery, announced a collaboration to develop new therapies for a range of
Kazakhstan legislation
The Code of the Republic of Kazakhstan dated on September 18, 2009 No 193-IV
On public health and health care system (Unofficial translation)
